Chronic graft-versus-host disease (cGVHD) is a major complication of allogeneic hematopoietic cell transplantation that is associated with a diminished quality of life. The oral cavity is frequently affected, with a wide variety of signs and symptoms that can result in significant short-and long-term complications ranging from mucosal sensitivity and limited oral intake to secondary malignancy and early death. This article provides a comprehensive approach to the diagnosis and clinical management of patients with oral cGVHD, with particular attention to differential diagnosis, control of symptoms, and prevention of and screening for secondary complications. The clinical considerations and recommendations presented are intended to be practical and relevant for all clinicians involved in the care of patients with oral cGVHD, with the ultimate goal of improving care and outcomes. © 2012 by The American Society of Hematology.
CITATION STYLE
Treister, N., Duncan, C., Cutler, C., & Lehmann, L. (2012). How we treat oral chronic graft-versus-host disease. Blood, 120(17), 3407–3418. https://doi.org/10.1182/blood-2012-05-393389
Mendeley helps you to discover research relevant for your work.